Jun. 10 at 6:07 PM
$ADHC post from the company just now https://x.com/stockpicksnyc/status/1932492977382773160?s=46
“Glucoguard is a wholly (100%) owned operating division of ADHC”
Link to analyst report dated 6/2 issuing GlucoGuard a
$43M valuation: https://d1io3yog0oux5.cloudfront.net/harbingerresearch/media/cf29499818e4263671232f93c2967e52.pdf
Co also states “Glucoguard is a development partner with Dexcom (NASDAQ:
$DXCM)
$33 B Market Cap, Global Leader in Diabetes Management”
“Arete Bioscience is on Board as Bio Sevice Engineering Partner”
Many more alliances and partnerships to come”
The kicker is:
ADHC is currently trading at a *
$2.6M market cap (At the time of writing this message)
OS 1,460,000,000 x .0018 per share =
$2,628,000 Market cap
Follow the company account on X for further updates, they are very active ADHCMANAGEMENT